By Dr (Isobel) Mary Poynten

Journal articles

Grulich AE; Jin F; Poynten IM; Vajdic CM, 2011, 'HIV, cancer, and ageing', Sexual Health, 8, pp. 521 - 525, http://search.informit.com.au/documentSummary;dn=535749118010911;res=IELHEA

Poynten IM; Templeton DJ; Grulich AE, 2011, 'Sexually transmissible infections in aging HIV populations', Sexual Health, 8, pp. 508 - 511, http://search.informit.com.au/documentSummary;dn=535637320183362;res=IELHEA

Poynten IM; Grulich AE, 2011, 'The emerging role of antiretroviral agents in HIV prevention', Sexual Health, 8, pp. 137 - 139

Molano M; Tabrizi SN; Garland SM; Roberts JM; MacHalek DA; Phillips S; Chandler D; Hillman RJ; Grulich AE; Jin F; Poynten IM; Templeton DJ; Cornall AM; McCaffery K; Howard K; Farnsworth A; Fairley K; Prestage G; Carr A; Tong W; Law C; Acraman B; Crampton L; Feeney L; Fraissard E; Law M; McGrath P; Mellor R; Norris R; O'Dwyer M; Pendlebury S; Petoumenos K; Richards A; Schema L; Seeds D; Segelov E; Thurloe J; Varma R; Han A, 2010, 'CpG methylation analysis of hpv16 in laser capture microdissected archival tissue and whole tissue sections from high grade anal squamous intraepithelial lesions: A potential disease biomarker', PLoS ONE, 11, pp. e0160673, http://dx.doi.org/10.1371/journal.pone.0160673

Poynton M; Jin F; Prestage G; Kaldor JM; Imrie JC; Grulich AE, 2010, 'Attitudes towards new HIV biomedical prevention technologies among a cohort of HIV-negative gay men in Sydney, Australia', HIV Medicine, 11, pp. 282 - 288, http://dx.doi.org/10.1111/j.1468-1293.2009.00777.x

Poynton M; Jin F; Prestage G; Kaldor JM; Kippax SC; Grulich AE, 2010, 'Defining high HIV incidence subgroups of Australian homosexual men: implications for conducting HIV prevention trials in low HIV prevalence settings', HIV Medicine, 11, pp. 634 - 641, http://dx.doi.org/10.1111/j.1468-1293.2010.00833.x

Chen M; Millwood I; Wand HC; Poynten IM; Law MG; Kaldor JM; Wesselingh S; Price C; Clark L; Pauli J; Fairley CK, 2009, 'A randomized controlled trial of the safety of candidate microbicide SPL7013 gel when applied to the penis', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 50, pp. 375 - 380

Guinot D; Ho MT; Poynten IM; McAllister J; Pierce A; Pell CM; Grulich AE, 2009, 'Cost-effectiveness of HIV nonoccupational post-exposure prophylaxis in Australia', HIV Medicine, 10, pp. 199 - 208, http://dx.doi.org/10.1111/j.1468-1293.2008.00670.x

Poynten IM; Jin F; Mao L; Prestage G; Kippax SC; Kaldor JM; Imrie JC; Grulich AE, 2009, 'Nonoccupational postexposure prophylaxis, subsequent risk behaviour and HIV incidence in a cohort of Australian homosexual men', AIDS, 23, pp. 1119 - 1126, http://dx.doi.org/10.1097/QAD.0b013e32832c1776

Poynten IM; Millwood I; Falster M; Law MG; Andresen DN; Van Damme L; Kaldor JM, 2009, 'The safety of candidate vaginal microbicides since nonoxynol-9: A systematic review of published studies', AIDS, 23, pp. 1245 - 1254

Poynten IM; Brown J; Sovero M; Millwood I; Kaldor JM, 2008, 'Microbicide safety and effectiveness: an overview of recent clinical trials', Current opinion in HIV & AIDS, 3, pp. 574 - 580

Poynten IM; Smith DE; Cooper DA; Kaldor JM; Grulich AE, 2007, 'The public health impact of widespread availability of nonoccupational postexposure prophylaxis against HIV', HIV Medicine, 8, pp. 374 - 381

Poynten IM; Hanlon M; Irwig L; Gilbert GL, 2002, 'Serological diagnosis of pertussis: Evaluation of IgA against whole cell and specific Bordetella pertussis antigens as markers of recent infection', Epidemiology and Infection, 128, pp. 161 - 167, http://dx.doi.org/10.1017/S0950268801006598

Poynten M, 1999, 'Actinomycosis: An unusual neck lump', Current Therapeutics, 40, pp. 40 - 41

Back to profile page